Viewing Study NCT00190892


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-01-07 @ 9:55 AM
Study NCT ID: NCT00190892
Status: COMPLETED
Last Update Posted: 2007-01-26
First Post: 2005-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 7031
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators